All News #Library
Biotech
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 May 2023 //
GLOBENEWSWIRE
Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company
06 Mar 2023 //
GLOBENEWSWIRE
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
05 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support